Innoviva (INVA) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.41% |
| Dec 31, 2025 | 25.68% |
| Sep 30, 2025 | 16.04% |
| Jun 30, 2025 | 8.87% |
| Mar 31, 2025 | -1.04% |
| Dec 31, 2024 | 4.63% |
| Sep 30, 2024 | 3.66% |
| Jun 30, 2024 | 9.54% |
| Mar 31, 2024 | 12.20% |
| Dec 31, 2023 | 0.98% |
| Sep 30, 2023 | -10.51% |
| Jun 30, 2023 | -1.71% |
| Mar 31, 2023 | 2.01% |
| Dec 31, 2022 | 32.93% |
| Sep 30, 2022 | 49.65% |
| Jun 30, 2022 | 44.16% |
| Mar 31, 2022 | 1.76% |
| Dec 31, 2021 | -7.32% |
| Sep 30, 2021 | -3.80% |
| Jun 30, 2021 | -10.29% |
| Mar 31, 2021 | 38.11% |
| Dec 31, 2020 | 37.90% |
| Sep 30, 2020 | 36.44% |
| Jun 30, 2020 | 36.95% |
| Mar 31, 2020 | 33.54% |
| Dec 31, 2019 | 32.22% |
| Sep 30, 2019 | 143.42% |
| Jun 30, 2019 | 89.64% |
| Mar 31, 2019 | 113.23% |
| Dec 31, 2018 | 49.23% |
| Sep 30, 2018 | -28.97% |
| Jun 30, 2018 | -8.96% |
| Mar 31, 2018 | -29.38% |
| Dec 31, 2017 | -3.08% |
| Sep 30, 2017 | 5.51% |
| Jun 30, 2017 | -1.61% |
| Mar 31, 2017 | 1.04% |
| Dec 31, 2016 | -7.32% |
| Sep 30, 2016 | -15.33% |
| Jun 30, 2016 | -18.17% |
| Mar 31, 2016 | -20.64% |
| Dec 31, 2015 | -21.61% |
| Sep 30, 2015 | -20.96% |
| Jun 30, 2015 | -23.70% |
| Mar 31, 2015 | -19.23% |
| Dec 31, 2014 | -23.43% |
| Sep 30, 2014 | -16.86% |
| Jun 30, 2014 | 1.83% |
| Mar 31, 2014 | 2.28% |
| Dec 31, 2013 | 84.83% |
| Sep 30, 2013 | 73.47% |
| Jun 30, 2013 | 48.89% |
| Mar 31, 2013 | 171.68% |
| Dec 31, 2012 | 42.43% |
| Sep 30, 2012 | 35.51% |
| Jun 30, 2012 | 31.77% |
| Dec 31, 2011 | -21.87% |